Impact of superdisintegrants on efavirenz release from tablet formulations

Rajesh, Yelchuri; Balasubramaniam, Jagdish; Bindu, Koduri; Sridevi, Ramachandran; Swetha, Maroju; Rao, Vinay

doi:10.2478/v10007-010-0019-6

Abstract

Efavirenz (EFV) tablets of different doses were prepared by a wet granulation process using different superdisintegrants such as crosscarmellose sodium (CCS), sodium starch glycollate (SSG) and crosspovidone (CP) to evaluate the role of different disintegrants on the in vitro release of EFV. Further, the mode of addition of disintegrants on EFV dissolution from tablets containing 600 mg of the drug was evaluated by incorporating the disintegrants extragranularly (EG), intragranularly (IG) or distributing them equally (IG and EG). In vitro dissolution of the prepared tablets was conducted using the recommended medium and a dissolution medium developed in-house, which had the ability to discriminate between the formulations.

The t₅₀ and t₈₀ values were indicative of the fact that the drug release was faster from tablet formulations containing CP. CP was able to release the drug faster than the other two disintegrants in both dissolution media and the drug release was unaffected by the mode of CP addition.

References

S. Sathigari, G. Chadha, Y-H. Lee, N. Wright, D. Parsons, V. Rathnagiri, O. Fasina and R. Babu, Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes, AAPS Pharm-SciTech. 10 (2009) 81-87; DOI: 10.1208/S12249-008-9180-3.10.1208/s12249-008-9180-3
Search in Google Scholar
K. Kesavan, V. U. Rao, K. Bindu, P. S. Rajinikanth, J. K. Pandit and J. Balasubramaniam, Immediate release tablets of valsartan and efavirenz: Role of concentration of superdisintegrant, Ars. Pharm. 49 (2008) 229-243.
Search in Google Scholar
W. T. Makooi-Morehead, J. D. Buehlar and B. R. Landmann, Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants, US Pat. 6,238,695 B1, 29 May 2001; http://www.freepatentsonline.com/65551333.html/
Search in Google Scholar
N. Zhao and L. L. Augsburger, The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressible tablets, AAPS PharmSciTech. 6 (2005) E120-126.10.1208/pt060119
Search in Google Scholar
Food and Drug Administration Department, Efavirenz http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm?PrintAll=1
Search in Google Scholar
J. Balasubramaniam, K. Bindu, V. U. Rao, D. Ray, R. Haldar and A. W. Brzeczko, Effect of superdisintegrants on dissolution of cationic drugs, Dissol. Technol. 15 (2008) 18-25.10.14227/DT150208P18
Search in Google Scholar
M. S. Gordon, V. S. Rudraraju, K. Dani and Z. T. Chowhan, Effect of the mode of superdisintegrants incorporation on dissolution in wet granulated tablets, J. Pharm. Sci. 82 (1993) 220-226.10.1002/jps.2600820222
Search in Google Scholar
B. Preetha, J. K. Pandit, V. U. Rao, K. Bindu, Y. V. Rajesh and J. Balasubramaniam, Comparative evaluation of mode of incorporation of superdisintegrants on dissolution of model drugs from wet granulated tablets, Acta Pharm. Sci. 50 (2008) 229-236.
Search in Google Scholar
Y. S. Yen, C. R. Chen, M. T. Lee and L. C. Chen, Investigation of dissolution enhancement of nifedipine by deposition on superdisintegrants, Drug. Dev. Ind. Pharm. 23 (1997) 313-317; DOI: 10.3109/03639049709149809.10.3109/03639049709149809
Search in Google Scholar
J. Kukura, J. L. Baxter and F. J. Muzzio, Shear distribution and variability in the USP apparatus 2 under turbulent conditions, Int. J. Pharm. 279 (2004) 9-17; DOI: 10.1016/j.ijpharm.2004.03.033.10.1016/j.ijpharm.2004.03.033
Search in Google Scholar
L. G. McCarthy, C. Kosiol, A. M. Healy, G. Bradley, J. C. Sexton and O. I. Corrigan, Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus, AAPS Pharm. Sci.Tech. 4 (2005) 1-16.
Search in Google Scholar
S. A. Qureshi and J. Shabnam, Cause of high variability in drug dissolution testing and its impact on setting tolerances, Eur. J. Pharm. Sci. 12 (2001) 271-276; DOI: 10.1016/S0928-0987(00)00174-3.10.1016/S0928-0987(00)00174-3
Search in Google Scholar
S. A. Qureshi, Developing discriminatory drug dissolution tests and profiles: Some thoughts for consideration on the concept and its interpretation, Dissol. Technol. 13 (2006) 18-23.
Search in Google Scholar
M. S. Kim, S. J. Jin, J. S. Kim, H. J. Park, H. S. Song, R. H. H. Neubert and S. J. Hwang, Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm. 69 (2008) 454-465; DOI: 10.1016/j.ejpb.2008.01.007.10.1016/j.ejpb.2008.01.00718359211
Search in Google Scholar

Impact of superdisintegrants on efavirenz release from tablet formulations

Abstract

Paradigm

My account